Keikavoussi P - Search Results

1

Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin.

Otto K, Andersen MH, Eggert A, Keikavoussi P, Pedersen LØ, Rath JC, Böck M, Bröcker EB, Straten PT, Kämpgen E, Becker JC. Otto K, et al. Among authors: keikavoussi p. Vaccine. 2005 Jan 4;23(7):884-9. doi: 10.1016/j.vaccine.2004.08.007. Vaccine. 2005. PMID: 15603888

2

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin.

Wobser M, Keikavoussi P, Kunzmann V, Weininger M, Andersen MH, Becker JC. Wobser M, et al. Among authors: keikavoussi p. Cancer Immunol Immunother. 2006 Oct;55(10):1294-8. doi: 10.1007/s00262-005-0102-x. Epub 2005 Nov 29. Cancer Immunol Immunother. 2006. PMID: 16315030 Free PMC article. Clinical Trial.

3

Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells.

Schrama D, Pedersen LØ, Keikavoussi P, Andersen MH, Straten Pt Pt, Bröcker EB, Kämpgen E, Becker JC. Schrama D, et al. Among authors: keikavoussi p. J Invest Dermatol. 2002 Dec;119(6):1443-8. doi: 10.1046/j.1523-1747.2002.19604.x. J Invest Dermatol. 2002. PMID: 12485452 Free article.

4

Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression.

Andersen MH, Keikavoussi P, Bröcker EB, Schuler-Thurner B, Jonassen M, Søndergaard I, Straten PT, Becker JC, Kämpgen E. Andersen MH, et al. Among authors: keikavoussi p. Int J Cancer. 2001 Dec 15;94(6):820-4. doi: 10.1002/ijc.1536. Int J Cancer. 2001. PMID: 11745484

5

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Thurner B, Haendle I, Röder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Bröcker EB, Steinman RM, Enk A, Kämpgen E, Schuler G. Thurner B, et al. Among authors: keikavoussi p. J Exp Med. 1999 Dec 6;190(11):1669-78. doi: 10.1084/jem.190.11.1669. J Exp Med. 1999. PMID: 10587357 Free PMC article. Clinical Trial.

6

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells.

Schuler-Thurner B, Dieckmann D, Keikavoussi P, Bender A, Maczek C, Jonuleit H, Röder C, Haendle I, Leisgang W, Dunbar R, Cerundolo V, von Den Driesch P, Knop J, Bröcker EB, Enk A, Kämpgen E, Schuler G. Schuler-Thurner B, et al. Among authors: keikavoussi p. J Immunol. 2000 Sep 15;165(6):3492-6. doi: 10.4049/jimmunol.165.6.3492. J Immunol. 2000. PMID: 10975870 Clinical Trial.

7

Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features.

Hartmann A, Bedenk C, Keikavoussi P, Becker JC, Hamm H, Bröcker EB. Hartmann A, et al. Among authors: keikavoussi p. J Dtsch Dermatol Ges. 2008 Dec;6(12):1053-9. doi: 10.1111/j.1610-0387.2008.06755.x. Epub 2008 May 7. J Dtsch Dermatol Ges. 2008. PMID: 18479500 English, German.

8

Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression.

Schnorr JJ, Xanthakos S, Keikavoussi P, Kämpgen E, ter Meulen V, Schneider-Schaulies S. Schnorr JJ, et al. Among authors: keikavoussi p. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5326-31. doi: 10.1073/pnas.94.10.5326. Proc Natl Acad Sci U S A. 1997. PMID: 9144236 Free PMC article.

9

Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells.

Neumann M, Fries H, Scheicher C, Keikavoussi P, Kolb-Mäurer A, Bröcker E, Serfling E, Kämpgen E. Neumann M, et al. Among authors: keikavoussi p. Blood. 2000 Jan 1;95(1):277-85. Blood. 2000. PMID: 10607713 Free article.

10

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.

Schadendorf D, Ugurel S, Schuler-Thurner B, Nestle FO, Enk A, Bröcker EB, Grabbe S, Rittgen W, Edler L, Sucker A, Zimpfer-Rechner C, Berger T, Kamarashev J, Burg G, Jonuleit H, Tüttenberg A, Becker JC, Keikavoussi P, Kämpgen E, Schuler G; DC study group of the DeCOG. Schadendorf D, et al. Among authors: keikavoussi p. Ann Oncol. 2006 Apr;17(4):563-70. doi: 10.1093/annonc/mdj138. Epub 2006 Jan 17. Ann Oncol. 2006. PMID: 16418308 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters